Search hospitals

>

Massachusetts

>

Boston

Tufts Medical Center

Claim this profile

Boston, Massachusetts 02111

Global Leader in Heart Failure

Global Leader in Breast Cancer

Conducts research for Pulmonary Arterial Hypertension

Conducts research for Pulmonary Hypertension

Conducts research for Multiple Myeloma

863 reported clinical trials

61 medical researchers

Photo of Tufts Medical Center in BostonPhoto of Tufts Medical Center in BostonPhoto of Tufts Medical Center in Boston

Summary

Tufts Medical Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of Heart Failure, Breast Cancer, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Multiple Myeloma and other specialties. Tufts Medical Center is involved with conducting 863 clinical trials across 955 conditions. There are 61 research doctors associated with this hospital, such as Jason Law, Katina M. Robison, Nicholas S Hill, MD, and Andreas K. Klein.

Area of expertise

1

Heart Failure

Global Leader

Tufts Medical Center has run 55 trials for Heart Failure. Some of their research focus areas include:

Stage III
2

Breast Cancer

Global Leader

Tufts Medical Center has run 46 trials for Breast Cancer. Some of their research focus areas include:

ER positive
Stage II
Stage I

Top PIs

Clinical Trials running at Tufts Medical Center

Multiple Myeloma

Breast Cancer

Lung Cancer

Cancer

Heart Failure

Testicular cancer

Glioblastoma

Brain Tumor

Pancreatic Cancer

Multiple Sclerosis

Image of trial facility.

Teclistamab + Lenalidomide

for Multiple Myeloma

This is a multicenter, randomized, open-label, Phase 3 study in participants with newly diagnosed multiple myeloma to evaluate the benefits of teclistamab in combination with lenalidomide and teclistamab alone versus lenalidomide alone as maintenance therapy after autologous stem cell transplant.

Recruiting

3 awards

Phase 3

5 criteria

Image of trial facility.

Tec-DR and Tal-DR

for Multiple Myeloma

This trial is testing two new drug combinations to see if they work better than the current standard treatment for multiple myeloma. The new treatments aim to help the immune system find and destroy cancer cells more effectively.

Recruiting

2 awards

Phase 3

5 criteria

Image of trial facility.

Lenalidomide + Dexamethasone +/- Daratumumab

for Multiple Myeloma

This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving lenalidomide and dexamethasone with daratumumab may work better in treating patients with smoldering myeloma.

Recruiting

2 awards

Phase 3

12 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Tufts Medical Center?

Where is Tufts Medical Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does Tufts Medical Center accept?

What awards or recognition has Tufts Medical Center received?